| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.328 | 12.056 | 6.899 | 10.771 | 18.029 | 12.861 | 10.872 | 18.697 | 16.279 | 21.524 |
| Total Income - EUR | 12.328 | 12.134 | 6.899 | 10.926 | 18.029 | 12.861 | 10.872 | 18.698 | 16.279 | 21.525 |
| Total Expenses - EUR | 7.042 | 3.421 | 5.375 | 9.201 | 9.850 | 6.243 | 4.704 | 4.224 | 7.088 | 10.731 |
| Gross Profit/Loss - EUR | 5.287 | 8.713 | 1.525 | 1.725 | 8.179 | 6.618 | 6.168 | 14.473 | 9.191 | 10.795 |
| Net Profit/Loss - EUR | 4.917 | 8.349 | 1.304 | 1.397 | 7.638 | 6.227 | 5.842 | 13.895 | 7.712 | 8.696 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oralmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.025 | 5.250 | 5.539 | 3.204 | 0 | 0 | 0 | 53 | 53 | 0 |
| Current Assets | 13.206 | 20.649 | 21.267 | 9.349 | 20.479 | 27.015 | 32.290 | 46.275 | 35.018 | 10.707 |
| Inventories | 2.120 | 1.482 | 568 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Receivables | 9.249 | 3.112 | 2.991 | 4.223 | 4.338 | 4.608 | 5.120 | 5.998 | 6.463 | 1.605 |
| Cash | 1.837 | 16.055 | 17.708 | 5.126 | 16.141 | 22.407 | 27.170 | 40.277 | 28.556 | 9.096 |
| Shareholders Funds | 17.185 | 25.358 | 26.233 | 11.911 | 19.318 | 25.179 | 30.462 | 44.452 | 30.195 | 8.744 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 46 | 540 | 585 | 642 | 1.160 | 1.836 | 1.828 | 1.876 | 4.876 | 2.003 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Oralmed S.r.l.